Advertisement
Loading...

AstraZeneca PLC

AZN•NYSE
Healthcare
Drug Manufacturers - General
$181.58
$-3.38(-1.83%)
U.S. Market opens in 27h 11m

AstraZeneca PLC (AZN) Stock Overview

Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap281.8B
P/E Ratio27.10
EPS (TTM)$6.65
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Month$190.57
3 Months$98.17
1 Year Target$94.29

AZN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AstraZeneca PLC (AZN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $94.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.10 and a market capitalization of 281.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.77%
5-Day Change
-0.56%
1-Month Change
-9.71%
3-Month Change
-11.61%
6-Month Change
3.92%
Year-to-Date (YTD) Change
3.52%
1-Year Change
33.71%
3-Year Change
21.57%
5-Year Change
62.04%
All-Time (Max) Change
1702.38%

Contact Information

https://www.astrazeneca.com
44 20 3749 5000
1 Francis Crick Avenue, Cambridge, NaN, CB2 0AA

Company Facts

94,300 Employees
IPO DateMay 12, 1993
CountryGB
Actively Trading

Frequently Asked Questions